Citations (175)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Selina Ladina Combertaldi & Björn Rasch. (2020) Healthy Sleepers Can Worsen Their Sleep by Wanting to Do so: The Effects of Intention on Objective and Subjective Sleep Parameters. Nature and Science of Sleep 12, pages 981-997.
Read now
Read now
Vural Özdemir, Karen E. Bremner & Claudio A. Naranjo. (1994) Treatment of Alcohol Withdrawal Syndrome. Annals of Medicine 26:2, pages 101-105.
Read now
Read now
Fiona K. Judd, Trevor R. Norman & Graham D. Burrows. (1990) Pharmacotherapy of Panic Disorder. International Review of Psychiatry 2:3-4, pages 399-409.
Read now
Read now
Erling N. Petersen. (1989) A Possible Cause of Benzodiazepine Tolerance. Nordisk Psykiatrisk Tidsskrift 43:4, pages 309-314.
Read now
Read now
Malcolm Lader. (1984) Dependence on Benzodiazepines. Nordisk Psykiatrisk Tidsskrift 38:5, pages 509-512.
Read now
Read now
J. E. Lapp, R. Marinier & R. O. Pihl. (1983) Medical Drug Use by Women: Symptoms and Change Attributions. International Journal of the Addictions 18:1, pages 45-51.
Read now
Read now
Gábor Maksay & László Ötvös. (1983) Bioactivation of Prodrugs: Structure-Pharmacokinetic Correlations of Benzodiazepine Esters. Drug Metabolism Reviews 14:6, pages 1165-1192.
Read now
Read now
Karl Rickels. (1983) Benzodiazepines in Emotional Disorders. Journal of Psychoactive Drugs 15:1-2, pages 49-54.
Read now
Read now
Glenda L. Mackinnon & William A. Parker. (1982) Benzodiazepine Withdrawal Syndrome: A Literature Review and Evaluation. The American Journal of Drug and Alcohol Abuse 9:1, pages 19-33.
Read now
Read now
Articles from other publishers (166)
William O. Tatum, Tracy Glauser, Jurriaan M. Peters, Amit Verma, Sarah Weatherspoon, Selim Benbadis, Danielle A. Becker, Vinay Puri, Michael Smith, Sunita N. Misra, Adrian L. Rabinowicz & Enrique Carrazana. (2023) Acute seizure therapies in people with epilepsy: Fact or fiction? A U.S. Perspective. Epilepsy & Behavior Reports 23, pages 100612.
Crossref
Crossref
Yaron Ilan. (2022) Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases. Journal of Personalized Medicine 12:8, pages 1303.
Crossref
Crossref
Eric R. Braverman, Catherine A. Dennen, Mark S. Gold, Abdalla Bowirrat, Ashim Gupta, David Baron, A. Kenison Roy, David E. Smith, Jean Lud Cadet & Kenneth Blum. (2022) Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health 19:9, pages 5480.
Crossref
Crossref
Maurice Wilde, Volker Auwärter & Bjoern Moosmann. (2021) New psychoactive substances—Designer benzodiazepines. WIREs Forensic Science 3:6.
Crossref
Crossref
Gregory D. Cascino, Daniel Tarquinio, James W. Wheless, R. Edward Hogan, Michael R. Sperling, Kore Liow, Jay Desai, Charles Davis, Adrian L. Rabinowicz & Enrique Carrazana. (2021) Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study. Epilepsy & Behavior 120, pages 107983.
Crossref
Crossref
Eric B. Segal, Daniel Tarquinio, Ian Miller, James W. Wheless, Dennis Dlugos, Victor Biton, Gregory D. Cascino, Jay Desai, R. Edward Hogan, Kore Liow, Michael R. Sperling, Blanca Vazquez, David F. Cook, Adrian L. Rabinowicz & Enrique Carrazana. (2021) Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study. Epilepsia 62:6, pages 1442-1450.
Crossref
Crossref
Gerardo Abraham Fridman. (2021) Use of psychotropic drugs during the argentine quarantine due to the COVID-19 pandemic. Pharmacy & Pharmacology International Journal 9:2, pages 39-43.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz, Qingchen Zhang, Yuxi Chen & Richard I. Shader. (2020) Slow Accumulation and Elimination of Diazepam and Its Active Metabolite With Extended Treatment in the Elderly. The Journal of Clinical Pharmacology 61:2, pages 193-203.
Crossref
Crossref
Hicham El Assli, Mohamed Merzouki, Fatiha Chigr, Abdelmohcine Aimrane & Mohamed Najimi. (2020) Status of addictions to psychoactive substances among students in the province of Béni Mellal, Morocco. Children and Youth Services Review 117, pages 105267.
Crossref
Crossref
Julia Machado Khoury, João Pedro Sousa Drumond, Letícia Lopes de Carvalho e Silva, Mariane da Silva Melo, Mariane da Silva Melo, Ananda Araujo Teixeira, Maila de Castro Lourenço das Neves & Frederico Duarte Garcia. (2020) Fatores associados à dependência de smartphone: uma revisão da literatura. Debates em Psiquiatria 10:3, pages 34-57.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz & Richard I. Shader. (2020) Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence. Journal of Clinical Psychopharmacology 40:3, pages 215-219.
Crossref
Crossref
Gerardo Fridman & Amelio Presman. (2019) Epidemiological study of the consumption of psychotropic’s in the northeast region of Argentina . Pharmacy & Pharmacology International Journal 7:3.
Crossref
Crossref
Fatma Tuğçe Gürağaç Dereli, Mert Ilhan & Esra Küpeli Akkol. (2018) Discovery of new antidepressant agents: In vivo study on Anthemis wiedemanniana Fisch. & Mey. Journal of Ethnopharmacology 226, pages 11-16.
Crossref
Crossref
Yoohun Noh, Seungui Cheon, In Hye Kim, Inyong Kim, Seung-Ah Lee, Do-Hee Kim & Yoonhwa Jeong. (2018)
The protective effects of ethanolic extract of
Clematis terniflora
against corticosterone-induced neuronal damage via the AKT and ERK1/2 pathway
. BMB Reports 51:8, pages 400-405.
Crossref
Crossref
Daniala L. Weir, Salim Samanani, Fizza Gilani, Ed Jess & Dean T. Eurich. (2018) Benzodiazepine receptor agonist dispensations in Alberta: a population-based descriptive study. CMAJ Open 6:4, pages E678-E684.
Crossref
Crossref
Jonathan Henssler, Theresa Schubert & Michael Soyka. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
585
607
.
Mariela Fernanda Pérez. (2017) Diazepam Withdrawal Expression is related to Hippocampal NOS-1 Upregulation. Archives of Pharmacy and Pharmaceutical Sciences 2:1, pages 001-009.
Crossref
Crossref
Jonathan Henssler, Theresa Schubert & Michael Soyka. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
30
.
Nicholas E. Calcaterra & James C. Barrow. (2014) Classics in Chemical Neuroscience: Diazepam (Valium). ACS Chemical Neuroscience 5:4, pages 253-260.
Crossref
Crossref
Jeannette Y. Wick. (2013) The History of Benzodiazepines. The Consultant Pharmacist 28:9, pages 538-548.
Crossref
Crossref
Azusa Sugiyama, Akiyoshi Saitoh, Takashi Iwai, Kou Takahashi, Misa Yamada, Sachie Sasaki-Hamada, Jun-Ichiro Oka, Masatoshi Inagaki & Mitsuhiko Yamada. (2012) Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Neuropharmacology 62:8, pages 2489-2498.
Crossref
Crossref
Francisco López-Muñoz, Cecilio Álamo & Pilar García-García. (2011) The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs. Journal of Anxiety Disorders 25:4, pages 554-562.
Crossref
Crossref
Richard G ListerSandra E File. (1983) Changes in regional concentrations in the rat brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid during the development of tolerance to the sedative action of chlordiazepoxide. Journal of Pharmacy and Pharmacology 35:9, pages 601-603.
Crossref
Crossref
Sahruh Turkmen, Torbjorn Backstrom, Goran Wahlstrom, Lotta Andreen & Inga‐Maj Johansson. (2010) Tolerance to allopregnanolone with focus on the GABA‐A receptor. British Journal of Pharmacology 162:2, pages 311-327.
Crossref
Crossref
Donald J Nicolson, Peter Knapp, David K Raynor & Pat Spoor. (2009) Written information about individual medicines for consumers. Cochrane Database of Systematic Reviews 2017:8.
Crossref
Crossref
Şahruh Türkmen, Göran Wahlström, Torbjörn Bäckström & Inga-Maj Johansson. (2008) Persistence of tolerance to the anaesthetic effect of allopregnanolone in male rats. European Journal of Pharmacology 592:1-3, pages 73-80.
Crossref
Crossref
Akiko Hirao, Aki Imai, Yutaka Sugie, Yoshinari Yamada, Shigeo Hayashi & Katsuo Toide. (2008) Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ–Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent. Journal of Pharmacological Sciences 106:3, pages 361-368.
Crossref
Crossref
Ş. Türkmen, M. Löfgren, V. Birzniece, T. Bäckström & I.-M. Johansson. (2006) Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 139:2, pages 651-659.
Crossref
Crossref
H Ihmsen, M Schywalsky, A Tzabazis & H Schwilden. (2005) Development of acute tolerance to the EEG effect of propofol in rats † †Presented in part at the Euroanaesthesia meeting, Lisbon, Portugal, June 5–8, 2004.. British Journal of Anaesthesia 95:3, pages 367-371.
Crossref
Crossref
Nora A Isoardi, Irene D Martijena, Hugo F Carrer & Víctor A Molina. (2004) Increased Fear Learning Coincides with Neuronal Dysinhibition and Facilitated LTP in the Basolateral Amygdala following Benzodiazepine Withdrawal in Rats. Neuropsychopharmacology 29:10, pages 1852-1864.
Crossref
Crossref
James Auta, Erminio Costa, John Davis & Alessandro Guidotti. (2004) Imidazenil: a potent and safe protective agent against diisopropyl fluorophosphate toxicity. Neuropharmacology 46:3, pages 397-403.
Crossref
Crossref
Harald Ihmsen, Sven Albrecht, Werner Hering, Jürgen Schüttler & Helmut Schwilden. (2003) Modelling acute tolerance to the EEG effect of two benzodiazepines. British Journal of Clinical Pharmacology 57:2, pages 153-161.
Crossref
Crossref
Frederic Stiefel & Daniele Stagno. (2004) Management of Insomnia in Patients with Chronic Pain Conditions. CNS Drugs 18:5, pages 285-296.
Crossref
Crossref
Mariela F Pérez, Romina Salmirón & Oscar A Ramı́rez. (2003) NMDA-NR1 and -NR2B subunits mRNA expression in the hippocampus of rats tolerant to Diazepam. Behavioural Brain Research 144:1-2, pages 119-124.
Crossref
Crossref
Marcel G. Smits, Elsbeth E. Nagtegaal, Janine van der Heijden, Anton M.L. Coenen & Gerard A. Kerkhof. (2016) Melatonin for Chronic Sleep Onset Insomnia in Children: A Randomized Placebo-Controlled Trial. Journal of Child Neurology 16:2, pages 86-92.
Crossref
Crossref
Gupta Nidhi, V.K. Bhargava & P. Pandhi. (2000) Tolerance to and Withdrawal from Anticonvulsant Action of Diazepam: Role of Nitric Oxide. Epilepsy & Behavior 1:4, pages 262-270.
Crossref
Crossref
A Chistina Grobin, Jon R Inglefield, Rochelle D Schwartz-Bloom, Leslie L Devaud & A.Leslie Morrow. (1999) Fluorescence imaging of GABAA receptor-mediated intracellular [Cl−] in P19-N cells reveals unique pharmacological properties. Brain Research 827:1-2, pages 1-11.
Crossref
Crossref
Carolina Lacerra, Irene D. Martijena, Silvia G. Bustos & Vı́ctor A. Molina. (1999) Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs. Brain Research 819:1-2, pages 40-47.
Crossref
Crossref
JUN ISHIGOOKA, TAKESHI SUGIYAMA, MAKIHIKO SUZUKI, KAZUHIRO KOBAYASHI, HISAKO TAKEUCHI & MITSUKUNI MURASAKI. (2002) Survival analytic approach to long‐term prescription of benzodiazepine hypnotics. Psychiatry and Clinical Neurosciences 52:5, pages 541-545.
Crossref
Crossref
M. Srisurapanont & N. Jarusuraisin. (2007) Amitriptyline vs. lorazepam in the treatment of opiate‐withdrawal insomnia: a randomized double‐blind study. Acta Psychiatrica Scandinavica 97:3, pages 233-235.
Crossref
Crossref
Fiona H Marshall, Sharon C Stratton, Joanne Mullings, Elaine Ford, Stella P Worton, Nigel R Oakley & Russell M Hagan. (1997) Development of Tolerance in Mice to the Sedative Effects of the Neuroactive Steroid Minaxolone Following Chronic Exposure. Pharmacology Biochemistry and Behavior 58:1, pages 1-8.
Crossref
Crossref
Yaron Dagan, Nava Zisapel, Dina Nof, Moshe Laudon & Jacob Atsmon. (1997) Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report. European Neuropsychopharmacology 7:2, pages 157-160.
Crossref
Crossref
Robert K McNamara & Ronald W Skeleton. (1997) Tolerance Develops to the Spatial Learning Deficit Produced by Diazepam in Rats. Pharmacology Biochemistry and Behavior 56:3, pages 383-389.
Crossref
Crossref
James A. MonnMatthew J. ValliSteven M. MasseyRebecca A. WrightCraig R. SalhoffBryan G. JohnsonTrevor HoweCharles A. AltGary A. RhodesRoger L. RobeyKelly R. GriffeyJoseph P. TizzanoMary J. KallmanDavid R. HeltonDarryle D. Schoepp. (1997) Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties. Journal of Medicinal Chemistry 40:4, pages 528-537.
Crossref
Crossref
Vicki A Ramsey-Williams & Donald B Carter. (1996) Chronic triazolam and its withdrawal alters GABAA receptor subunit mRNA levels: an in situ hybridization study. Molecular Brain Research 43:1-2, pages 132-140.
Crossref
Crossref
Raúl H. Marín, Nancy A. Salvatierra & Oscar A. Ramirez. (1996) Rapid tolerance to benzodiazepine modifies rat hippocampal synaptic plasticity. Neuroscience Letters 215:3, pages 149-152.
Crossref
Crossref
Maria J. Brown & David R. Bristow. (1996) Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor α1 subunit protein in rat cerebellar granule cells. British Journal of Pharmacology 118:5, pages 1103-1110.
Crossref
Crossref
J. Atsmon, S. Oaknin, M. Laudon, S. Laschiner, M. Gavish, Y. Dagan & N. Zisapel. (2007) Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites. Journal of Pineal Research 20:2, pages 65-71.
Crossref
Crossref
David R. Helton, James E. Berger, Janet F. Czachura, Kurt Rasmussen & Mary J. Kallman. (1996) Central nervous system characterization of the new cholecystokininB antagonist LY288513. Pharmacology Biochemistry and Behavior 53:3, pages 493-502.
Crossref
Crossref
Jed S. Shumsky & Irwin Lucki. (1996) Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment. Pharmacology Biochemistry and Behavior 53:3, pages 593-601.
Crossref
Crossref
Irene D. Martijena, Marcela Tapia & Víctor A. Molina. (1996) Altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats. Brain Research 712:2, pages 239-244.
Crossref
Crossref
Murray P. Ducharme & Paul Munzenberger. (2012) Severe Withdrawal Syndrome Possibly Associated With Cessation of a Midazolam and Fentanyl Infusion. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15:5, pages 665-668.
Crossref
Crossref
James M. McKenney, Jack D. Proctor, Jackson T. Wright, Robert J. Kolinski, R.K. Elswick & Jean S. Coaker. (2012) The Effect of Supplemental Dietary Fat on Plasma Cholesterol Levels in Lovastatin‐Treated Hypercholesterolemic Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15:5, pages 565-572.
Crossref
Crossref
. (2012) POSTER COMMUNICATIONS. British Journal of Pharmacology 114:S1.
Crossref
Crossref
J. Krska & T. N. N. MacLeod. (1995) Sleep quality and the use of benzodiazepine hypnotics in general practice. Journal of Clinical Pharmacy and Therapeutics 20:2, pages 91-96.
Crossref
Crossref
A. Leslie Morrow. 1995.
1
41
.
W. E. Müller. 1995. The Pharmacology of Sleep. The Pharmacology of Sleep
211
242
.
David J. Sanger, Jesús Benavides, Ghislaine Perrault, Eliane Morel, Caroline Cohen, Danielle Joly & Branimir Zivkovic. (1994) Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes. Neuroscience & Biobehavioral Reviews 18:3, pages 355-372.
Crossref
Crossref
T Duka, B Schutt, W Krause, R Dorow, S McDonald & K Fichte. (2012) Human studies on abecarnil a new beta‐carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.. British Journal of Clinical Pharmacology 35:4, pages 386-394.
Crossref
Crossref
John J. Byrnes, Lawrence G. Miller, David J. Greenblatt & Richard I. Shader. (1993) Chronic benzodiazepine administration. Psychopharmacology 111:1, pages 91-95.
Crossref
Crossref
S. Ishihara, M. Hiramatsu, T. Kameyama & T. Nabeshima. (1993) Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors. Journal of Neural Transmission 91:1, pages 27-37.
Crossref
Crossref
Graham D. Burrows, Fiona K. Judd & Trevor R. Norman. (1993) Long-term drug treatment of panic disorder. Journal of Psychiatric Research 27, pages 111-125.
Crossref
Crossref
Sei-ichi Ishihara, Masayuki Hiramatsu, Tsutomu Kameyama & Toshitaka Nabeshima. (1993) Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems. European Journal of Pharmacology 230:3, pages 313-319.
Crossref
Crossref
Philippe Chopin, Marie-Bernadette Assié & Mike Briley. (1993) Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3′-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. Psychopharmacology 110:1-2, pages 19-26.
Crossref
Crossref
Lawrence G. Miller. 1993. Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
91
96
.
John H. Arnold & Robert D. Truog. (1992) Sedation in Neonatal and Pediatric Intensive Care. Journal of Intensive Care Medicine 7:5, pages 244-260.
Crossref
Crossref
Annemiek M. Stijnen, Ineke Postel‐Westra, Mariska W.E. Langemeijer, Arendien Hoogerkamp, Rob A. Voskuyl, Cornelis F.A. van Bezooijen & Meindert Danhof. (2012) Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats. British Journal of Pharmacology 107:1, pages 165-170.
Crossref
Crossref
Marlene A. Wilson & Rosemary Biscardi. (1992) Effects of gender and gonadectomy on responses to chronic benzodiazepine receptor agonist exposure in rats. European Journal of Pharmacology 215:1, pages 99-107.
Crossref
Crossref
Michael J. Mana, C. Kwon Kim, John P.J. Pinel & C.H. Jones. (1992) Contingent tolerance to the anticonvulsant effects of carbamazepine, diazepam, and sodium valproate in kindled rats. Pharmacology Biochemistry and Behavior 41:1, pages 121-126.
Crossref
Crossref
Lawrence G. Miller, Shelley Chesley, Wendy R. Galpern, David J. Greenblatt & Richard I. Shader. (1991) Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [35S]TBPS binding but not benzodiazepine binding. Pharmacology Biochemistry and Behavior 40:2, pages 429-432.
Crossref
Crossref
Richard I. Shader, David J. Greenblatt & Mitchell B. Balter. (1991) Appropriate Use and Regulatory Control of Benzodiazepines. The Journal of Clinical Pharmacology 31:9, pages 781-784.
Crossref
Crossref
Inwha Kang & Lawrence G. Miller. (2012)
Decreased GABA
A
receptor subunit mRNA concentrations following chronic lorazepam administration
. British Journal of Pharmacology 103:2, pages 1285-1287.
Crossref
Crossref
Wendy R. Galpern, Monica Lumpkin, David J. Greenblatt, Richard I. Shader & Lawrence G. Miller. (1991) Chronic benzodiazepine administration. Psychopharmacology 104:2, pages 225-230.
Crossref
Crossref
Lawrence G. Miller. (2013) Chronic Benzodiazepine Administration: From the Patient to the Gene. The Journal of Clinical Pharmacology 31:6, pages 492-495.
Crossref
Crossref
Michel Bourin & Jacques Bradwejn. (2017) Aspects Cliniques et Neurobiologiques de L'Administration à Long Terme des Psychotropes*. The Canadian Journal of Psychiatry 36:4, pages 260-264.
Crossref
Crossref
Andrea Cittadini & Malcolm Lader. (2016) Lack of effect of a small dose of flumazenil in reversing short-term tolerance to benzodiazepines in normal subjects. Journal of Psychopharmacology 5:3, pages 220-227.
Crossref
Crossref
Ewa Jankowska, Olgierd Pucilowski & Wojciech Kostowski. (1991) Chronic oral treatment with diltiazem or verapamil decreases isolation-induced activity impairment in elevated plus maze. Behavioural Brain Research 43:2, pages 155-158.
Crossref
Crossref
Sietse F. De Boer, Jef L. Slangen & Jan Van Der Gugten. (1991) Effects of buspirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and nonstressed rats. Pharmacology Biochemistry and Behavior 38:2, pages 299-308.
Crossref
Crossref
Wendy R. Galpern, Lawrence G. Miller, David J. Greenblatt & Richard I. Shader. (1990) Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function. British Journal of Pharmacology 101:4, pages 839-842.
Crossref
Crossref
William K. Chiang & Lewis R. Goldfrank. (1990) Substance Withdrawal. Emergency Medicine Clinics of North America 8:3, pages 613-631.
Crossref
Crossref
C. Heninger, N. Saito, J. F. Tallman, K. M. Garrett, M. P. Vitek, R. S. Duman & D. W. Gallager. (1990) Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain. Journal of Molecular Neuroscience 2:2, pages 101-107.
Crossref
Crossref
S. Golombok, A. Mathews, C. Macleod & M. Lader. (1990) The effects of diazepam on cognitive processing. Human Psychopharmacology: Clinical and Experimental 5:2, pages 143-147.
Crossref
Crossref
Mark W. Pierce, Vincent S. Shu & Lesley J. Groves. (1990) Safety of estazolam. The American Journal of Medicine 88:3, pages S12-S17.
Crossref
Crossref
Mark Farrant, Terrell T. Gibbs & David H. Farb. (1990) Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: Electrophysiological and biochemical studies. Neurochemical Research 15:2, pages 175-191.
Crossref
Crossref
Graham D. Burrows, Trevor R. Norman, Fiona K. Judd & Peter F. Marriott. (1990) Short-acting versus long-acting benzodiazepines: Discontinuation effects in panic disorders. Journal of Psychiatric Research 24, pages 65-72.
Crossref
Crossref
Pietro Giusti, Alessandro Guidotti, Wojciech Danysz, James Auta & Erminio Costa. (1990) Neuropharmacological evidence for an interaction between the GABA uptake inhibitor Cl-966 and anxiolytic benzodiazepines. Drug Development Research 21:3, pages 217-225.
Crossref
Crossref
Lawrence G. Miller, Scott Woolverton, David J. Greenblatt, Fred Lopez, R.Beth Roy & Richard I. Shader. (1989) Chronic benzodiazepine administration. Biochemical Pharmacology 38:21, pages 3773-3777.
Crossref
Crossref
Andrew Schatzki, Fred Lopez, David J. Greenblatt, Richard I. Shader & Lawrence G. Miller. (2012) Lorazepam discontinuation promotes ‘inverse agonist’ effects of benzodiazepines. British Journal of Pharmacology 98:2, pages 451-454.
Crossref
Crossref
J. J. Driessen & T. B. Vree. 1989. Update 1989. Update 1989
586
595
.
H. M. Reincke, R. L. Gilmore & R. J. Kuhn. (1988) High-Dose Lorazepam Therapy for Status Epilepticus in a Pediatric Patient. Annals of Pharmacotherapy 22:11, pages 889-890.
Crossref
Crossref
Wolfgang Löscher & David N Stephens. (1988) Chronic treatment with diazepam or the inverse benzodiazepine receptor agonist FG 7142 causes differential changes in the effects of GABA receptor stimulation. Epilepsy Research 2:4, pages 253-259.
Crossref
Crossref
Susan Golombok, Parimala Moodley & Malcolm Lader. (2009) Cognitive impairment in long-term benzodiazepine users. Psychological Medicine 18:2, pages 365-374.
Crossref
Crossref
Michael Davis & Dorothy W. Gallagher. (1988) Continuous slow release of low levels of diazepam produces tolerance to its depressant and anxiolytic effects on the startle reflex. European Journal of Pharmacology 150:1-2, pages 23-33.
Crossref
Crossref
A. Higgitt, P. Fonagy & M. Lader. (2009) The natural history of tolerance to the benzodiazepines. Psychological Medicine. Monograph Supplement 13, pages 1-55.
Crossref
Crossref
L. Berggren, I. Eriksson, P. Mollenholt & M. Sunzel. (2008) Changes in respiratory pattern after repeated doses of diazepam and midazolam in healthy subjects. Acta Anaesthesiologica Scandinavica 31:8, pages 667-672.
Crossref
Crossref
Wolfgang Löscher, Dagmar Hönack & Ayman Hashem. (1987) Anticonvulsant efficacy of clonazepam and the β-carboline ZK 93423 during chronic treatment in amygdala-kindled rats. European Journal of Pharmacology 143:3, pages 403-414.
Crossref
Crossref
C. Schmauss, S. Apelt & H.M. Emrich. (1987) Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients. Brain Research Bulletin 19:3, pages 393-400.
Crossref
Crossref
Richard P. Swinson, Marlene E. Kirby & John C. Pecknold. (1987) Benzodiazepine dependence. Journal of Affective Disorders 13:2, pages 109-118.
Crossref
Crossref
LISA C. ROUTH, JOHN L. BLACK & J. ERIC AHLSKOG. (1987) Parkinson's Disease Complicated by Anxiety. Mayo Clinic Proceedings 62:8, pages 733-735.
Crossref
Crossref
S.E. File & S. Pellow. (1987) Behavioral pharmacology of minor tranquilizers. Pharmacology & Therapeutics 35:3, pages 265-290.
Crossref
Crossref
U. Borchard. 1986. Nutzen und Gefahren der Therapie mit Benzodiazepinen. Nutzen und Gefahren der Therapie mit Benzodiazepinen
15
25
.
D. J. Greenblatt, H. L. Friedman & R. I. Shader. 1986. Clinical Pharmacology in Psychiatry. Clinical Pharmacology in Psychiatry
62
71
.
Dallas Treit, V.M. Lolordo & D.E. Armstrong. (1986) The effects of diazepam on “fear” reactions in rats are modulated by environmental constraints on the rat's defensive repertoire. Pharmacology Biochemistry and Behavior 25:3, pages 561-565.
Crossref
Crossref
Phyllis K. Sher. (1986) Long-term exposure of cortical cell cultures to clonazepam reduces benzodiazepine receptor binding. Experimental Neurology 92:2, pages 360-368.
Crossref
Crossref
D. Butler & F.S. Messiha. (1986) Alcohol withdrawal and carbamazepine. Alcohol 3:2, pages 113-129.
Crossref
Crossref
A.D. Lê, J.M. Khanna, H. Kalant & F. Grossi. (1986) Tolerance to and cross-tolerance among ethanol, pentobarbital and chlordiazepoxide. Pharmacology Biochemistry and Behavior 24:1, pages 93-98.
Crossref
Crossref
U. Baumann, H. Bieber, E. M. Biniek, N. Birbaumer, W. Blankenburg, K. Böhme, W. Bräutigam, R. Cohen, H. Coper, H. Dilling, K. Ernst, W. Feuerlein, A. Finzen, T. Flohrschütz, H. Fox, H. Häfner, H. Heimann, K. Heinrich, G. Heinz, H. Henseler, I. Hößle, F. Holsboer, R. Jung, H. Kächele, P. Kitzig, W. König, H. Küfner, H. Kunze, H. Lauter, G. Laux, K. Lipke, D. Lorenzen, S. Maier, E. Mergenthaler, H. J. Möller, C. Müller, U. Müller, W. Pannenberg, M. Pawils, J. Peiffer, P. Pichot, W. Pittrich, D. Ploog, H. Radebold, M. Rassek, M. Rave-Schwank, D. Rössler, F. T. Rötzer-Zimmer, C. Rohde-Dachser, G. Schlesinger-Kipp, W. Senf, E. Strömgren, M. Teising & P. C. WaldmeierG. Laux & W. König. 1986. Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen. Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen
263
272
.
G. Laux & W. König. 1986. Benzodiazepine. Benzodiazepine
226
233
.
Paul CushmanJr.Jr.. 1986. Recent Developments in Alcoholism. Recent Developments in Alcoholism
61
83
.
Howard D. Cappell, Edward M. Sellers & Usoa Busto. 1986. Research Advances in Alcohol and Drug Problems. Research Advances in Alcohol and Drug Problems
53
126
.
Wolfgang Löscher & Wayne S. Schwark. (1985) Development of tolerance to the anticonvulsant effect of diazepam in amygdala-kindled rats. Experimental Neurology 90:2, pages 373-384.
Crossref
Crossref
D. N. Stephens & H. H. Schneider. (1985) Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity. Psychopharmacology 87:3, pages 322-327.
Crossref
Crossref
Dorothy W. Gallager, Andrea B. Malcolm, Stewart A. Anderson & Susan F. Gonsalvez. (1985) Continuous release of diazepam: Electrophysiological, biochemical and behavioral consequences. Brain Research 342:1, pages 26-36.
Crossref
Crossref
Howard C. Rosenberg & Ted H. Chiu. (1985) Time course for development of benzodiazepine tolerance and physical dependence. Neuroscience & Biobehavioral Reviews 9:1, pages 123-131.
Crossref
Crossref
Dallas Treit. (1985) Evidence that tolerance develops to the anxiolytic effect of diazepam in rats. Pharmacology Biochemistry and Behavior 22:3, pages 383-387.
Crossref
Crossref
Edward O. Bixler, Joyce D. Kales, Anthony Kales, Judith A. Jacoby & Constantin R. Soldatos. (2013) Rebound Insomnia and Elimination Half‐Life: Assessment of Individual Subject Response. The Journal of Clinical Pharmacology 25:2, pages 115-124.
Crossref
Crossref
Dallas Treit. (1985) Animal models for the study of anti-anxiety agents: A review. Neuroscience & Biobehavioral Reviews 9:2, pages 203-222.
Crossref
Crossref
Karl Rickels. 1985. The Benzodiazepines: Current Standards for Medical Practice. The Benzodiazepines: Current Standards for Medical Practice
97
109
.
H.-H. Frey. 1985. Antiepileptic Drugs. Antiepileptic Drugs
265
282
.
Neal R. Cutler & Prem K. Narang. (1984) Implications of Dosing Tricyclic Antidepressants and Benzodiazepines in Geriatrics. Psychiatric Clinics of North America 7:4, pages 845-861.
Crossref
Crossref
Laura Mele, Stefano Sagratella & Marino Massotti. (1984) Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro. Brain Research 323:1, pages 93-102.
Crossref
Crossref
B. Sweden. (1984) The EEG in hypnosedative drug withdrawal and dependence. European Archives of Psychiatry and Neurological Sciences 234:4, pages 268-274.
Crossref
Crossref
Arthur W.K. Chan. (1984) Effects of combined alcohol and benzodiazepine: A review. Drug and Alcohol Dependence 13:4, pages 315-341.
Crossref
Crossref
Ronald A. Weller & Sheldon H. Preskorn. (1984) Psychotropic drugs and alcohol: Pharmacokinetic and pharmaco dynamic interactions. Psychosomatics 25:4, pages 301-309.
Crossref
Crossref
D. W. Gallager, J. M. Lakoski, S. F. Gonsalves & S. L. Rauch. (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308:5954, pages 74-77.
Crossref
Crossref
Malcolm Lader. (1984) Benzodiazepine dependence. Progress in Neuro-Psychopharmacology and Biological Psychiatry 8:1, pages 85-95.
Crossref
Crossref
H. R. Ochs, D. J. Greenblatt, M. L�ttkenhorst & B. Verburg-Ochs. (1984) Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage. European Journal of Clinical Pharmacology 26:4, pages 499-503.
Crossref
Crossref
Malcolm Lader. 1984. Guidelines for the Use of Psychotropic Drugs. Guidelines for the Use of Psychotropic Drugs
303
313
.
M. Costa, H. Kirchner, U. Klotz, J. Kraker, R. Patierno & W. WernerUlrich Klotz. 1984. Essential and Non-Essential Metals Metabolites with Antibiotic Activity Pharmacology of Benzodiazepines Interferon Gamma Research. Essential and Non-Essential Metals Metabolites with Antibiotic Activity Pharmacology of Benzodiazepines Interferon Gamma Research
117
167
.
Usoa Busto, Jan Simpkins, Edward M. Sellers, Barry Sisson & Ruth Segal. (2010) Objective Determination of Benzodiazepine Use and Abuse in Alcoholics. British Journal of Addiction 78:4, pages 429-435.
Crossref
Crossref
Paula J. Prezioso & Joseph H. Neale. (1983) Benzodiazepine receptor binding by membranes from brain cell cultures following chronic treatment with diazepam. Brain Research 288:1-2, pages 354-358.
Crossref
Crossref
Jan Koch-Weser, David J. Greenblatt, Richard I. Shader & Darrell R. Abernethy. (1983) Current Status of Benzodiazepines. New England Journal of Medicine 309:7, pages 410-416.
Crossref
Crossref
Phyllis K. Sher. (2007) Reduced Benzodiazepine Receptor Binding in Cerebral Cortical Cultures Chronically Exposed to Diazepam. Epilepsia 24:3, pages 313-320.
Crossref
Crossref
Laverne C Johnson, Cheryl L Spinweber, Wesley F Seidel & William C Dement. (1983) Sleep spindle and delta changes during chronic use of a short-acting and a long-acting benzodiazepine hypnotic. Electroencephalography and Clinical Neurophysiology 55:6, pages 662-667.
Crossref
Crossref
Phyllis K. Sher, Robert E. Study, Joann Mazzetta, Jeffery L. Barker & Phillip G. Nelson. (1983) Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam. Brain Research 268:1, pages 171-176.
Crossref
Crossref
Richard G. Lister, Sandra E. File & David J. Greenblatt. (1983) The behavioural effects of Lorazepam are poorly related to its concentration in the brain. Life Sciences 32:17, pages 2033-2040.
Crossref
Crossref
J.G. Whitwam. (2007) Benzodiazepine receptors. Anaesthesia 38:2, pages 93-95.
Crossref
Crossref
Yvon D. Lapierre. (1983) Are all benzodiazepines clinically equivalent?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 7:4-6, pages 641-646.
Crossref
Crossref
Friedrich StrianFriedrich Strian. 1983. Angst. Angst
465
591
.
SE File & RG Lister. (2012) Do lorazeam‐induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation?. British Journal of Clinical Pharmacology 14:4, pages 545-550.
Crossref
Crossref
B. Robert Meyer. (1982) Benzodiazepines in the Elderly. Medical Clinics of North America 66:5, pages 1017-1035.
Crossref
Crossref
Howard C. Rosenberg & Ted H. Chiu. (1982) Nature of functional tolerance produced by chronic flurazepam treatment in the cat. European Journal of Pharmacology 81:3, pages 357-365.
Crossref
Crossref
Katsuaki Matsubara & Akira Matsushita. (1982) Changes in ambulatory activities and muscle relaxation in rats after repeated doses of diazepam. Psychopharmacology 77:3, pages 279-283.
Crossref
Crossref
Howard C. Rosenberg & Ted H. Chiu. (1982) An antagonist-induced benzodiazepine abstinence syndrome. European Journal of Pharmacology 81:1, pages 153-157.
Crossref
Crossref
John C. Pecknold, David J. McClure, Doris Fleuri & Heather Chang. (1982) Benzodiazpine withdrawal effects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 6:4-6, pages 517-522.
Crossref
Crossref
Renato D. Alarcon, Charlotte S. Jenkins, Diane E. Heestand, Lowell K. Scott & Larry Cantor. (1982) The effectiveness of progressive relaxation in chronic hemodialysis patients. Journal of Chronic Diseases 35:10, pages 797-802.
Crossref
Crossref
PR Bittencourt, P Wade, AT Smith & A Richens. (2012) The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.. British Journal of Clinical Pharmacology 12:4, pages 523-533.
Crossref
Crossref
REESE T. JONES, NEAL L. BENOWITZ & RONALD I. HERNING. (1981) Clinical Relevance of Cannabis Tolerance and Dependence. The Journal of Clinical Pharmacology 21:S1, pages 143S-152S.
Crossref
Crossref
H. Petursson & M. H. Lader. (2010) Benzodiazepine Dependence. British Journal of Addiction 76:2, pages 133-145.
Crossref
Crossref
H Petursson, E Shur, S Checkley, A Slade & MH Lader. (2012) A neuroendocrine approach to benzodiazepine tolerance and dependence.. British Journal of Clinical Pharmacology 11:5, pages 526-528.
Crossref
Crossref
B. Van Sweden & M. Dumon-Radermecker. (1981) Drug-Withdrawal Syndromes, EEG and Clinical Aspects. Clinical Electroencephalography 12:2, pages 50-56.
Crossref
Crossref
Howard C. Rosenberg & Ted H. Chiu. (1981) Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. European Journal of Pharmacology 70:4, pages 453-460.
Crossref
Crossref
M. M. Ghoneim, S. P. Mewaldt, J. L. Berie & J. V. Hinrichs. (1981) Memory and performance effects of single and 3-week administration of diazepam. Psychopharmacology 73:2, pages 147-151.
Crossref
Crossref
K Rickels. (2012) Are benzodiazepines overused and abused?. British Journal of Clinical Pharmacology 11:S1.
Crossref
Crossref
RI Shader & DJ Greenblatt. (2012) The use of benzodiazepines in clinical practice.. British Journal of Clinical Pharmacology 11:S1.
Crossref
Crossref
S. Garattini, S. Caccia, M. Carli & T. Mennini. 1981. Recent Advances in Neuropsycho-Pharmacology. Recent Advances in Neuropsycho-Pharmacology
351
364
.
L. R. Hines. 1981. Psychotropic Agents. Psychotropic Agents
359
393
.
P. Cushman & D. Benzer. (1980) Benzodiazepines and drug abuse: Clinical observations in chemically dependent persons before and during abstinence. Drug and Alcohol Dependence 6:6, pages 365-371.
Crossref
Crossref
David J. Greenblatt. (1980) Pharmacokinetic comparisons. Psychosomatics 21:10, pages 9-14.
Crossref
Crossref
Marcia Divoll Allen & David J. Greenblatt. 1980.
29
36
.
J. R. Bueno. 1980. Benzodiazepines. Benzodiazepines
209
211
.
P. Tyrer. 1980. Clinical Pharmacology & Therapeutics. Clinical Pharmacology & Therapeutics
368
372
.
David J. Greenblatt, Richard I. Shader, Jerold S. Harmatz & Anastasios Georgotas. (1979) Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate. Psychopharmacology 66:3, pages 289-290.
Crossref
Crossref
David H. Overstreet & Henry I. Yamamura. (1979) Receptor alterations and drug tolerance. Life Sciences 25:22, pages 1865-1877.
Crossref
Crossref
Joel G. Berger & Louis C. Iorio. 1979. Annual Reports in Medicinal Chemistry Volume 14. Annual Reports in Medicinal Chemistry Volume 14
22
30
.
Jan Koch-Weser, David J. Greenblatt & Richard I. Shader. (1978) Prazepam and Lorazepam, Two New Benzodiazepines. New England Journal of Medicine 299:24, pages 1342-1344.
Crossref
Crossref